Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Inherited Retinal Disease > Foundation Fighting Blindness announces updates to program that offers free genetic testing for patients with IRD
  • Inherited Retinal Disease

Foundation Fighting Blindness announces updates to program that offers free genetic testing for patients with IRD

Kerri Fitzgerald
Foundation Fighting Blindness appoints Peter Ginsberg as Executive Vice President, Corporate Development, Chief Business Officer

The Foundation Fighting Blindness announced its partnership with PreventionGenetics, a part of Exact Sciences, as its new genetic laboratory partner for the My Retina Tracker Genetic Testing Program; InformedDNA remains a genetic counseling partner for the program.

The program seeks to enhance research on inherited retinal diseases (IRDs) and address barriers to genetic testing and counseling for patients with IRDs by offering free testing for patients with IRD who meet certain eligibility criteria. More than 20,000 patients have received no-cost genetic testing as part of the program.

Recent changes to the program, originally launched in 2017, include transitioning the laboratory partner to PreventionGenetics, simplifying ordering procedures, and offering a more targeted gene panel for IRDs.

“We are excited to partner with PreventionGenetics to further advance the My Retina Tracker Genetic Testing Program,” said Todd Durham, PhD, senior vice president, clinical and outcomes research at the Foundation Fighting Blindness, in a press release. “This collaboration underscores our commitment to improving patient access to high-quality genetic testing, a critical component in accelerating the development of therapies for inherited retinal diseases.”

Reference

Foundation Fighting Blindness partners with PreventionGenetics and InformedDNA to advance My Retina Tracker® Genetic Testing Program. PRNewswire. May 15, 2024. Accessed May 17, 2024. https://www.prnewswire.com/news-releases/foundation-fighting-blindness-partners-with-preventiongenetics-and-informeddna-to-advance-my-retina-tracker-genetic-testing-program-302145368.html

Share

Related Content

  • Inherited Retinal Disease

Patients with inherited retinal diseases face elevated risk of multiple ocular complications

  • Inherited Retinal Disease

Low-dose atropine shows limited effect on myopia progression in children with IRDs

  • Inherited Retinal Disease

Emerging imaging technologies offer hope for inherited retinal disease management

  • Inherited Retinal Disease

Emerging therapies and treatment for rare retinal diseases: a look at the pipeline

  • Inherited Retinal Disease

Breakthroughs in Gene Therapy and Diagnostics: Advancing Treatments and Understanding

  • Inherited Retinal Disease

Limited myopia progression in CSNB patients may guide treatment approaches

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon